Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker To Strategic Advisory Board
Provectus Biopharmaceuticals, Inc. (PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced today that it has appointed Jacob M. Plotsker to its strategic advisory board.
Mr. Plotsker, age 46, is currently Director of IUS Strategy and Lifecycle Management at Bayer Healthcare. Jacob started his career as a staff accountant at Deloitte & Touche.